There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pulse Biosciences (PLSE – Research Report), Daré Bioscience (DARE – Research Report) and Bellerophon (BLPH – Research Report) with bullish sentiments. Pulse Biosciences (PLSE) H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Pulse Biosciences today and set a price target of $8.50. The company's shares closed last Thursday at $4.86, close to its 52-week low of $4.14. According to TipRanks.com, Ramakanth is a 4-star analyst with an average return of -4.5% and a 37.3% success rate.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pulse-biosciences-plse-dare-bioscience-dare-and-bellerophon-blph?utm_source=advfn.com&utm_medium=referral